-+ 0.00%
-+ 0.00%
-+ 0.00%

Novo Nordisk CEO: Despite losing exclusivity, simeglutide performed quite well in Canada.

智通财经·11/04/2026 10:17:11
语音播报
Novo Nordisk CEO: Despite losing exclusivity, simeglutide performed quite well in Canada.